On July 31, 2025, Acurx Pharmaceuticals, Inc. announced a reverse stock split of 1-for-20, effective at 4:01 PM on August 4, 2025, where shareholders will receive a consolidated share of stock for every 20 shares they currently own. This change will not affect the total number of authorized shares and is aimed at potentially improving the stock price on Nasdaq, under the symbol 'ACXP'.